I think you are ignoring the telehealth area which is what primarily and compellingly ResApdx is designed for...why do you keep speaking in terms of a face to face diagnosis of respiratory disease for ResApdx? Just for the continuous baiting of Andrew? Grow up hand back on table please...
- Forums
- ASX - By Stock
- RAP
- Ann: Agreement with Ilara Health to sell ResAppDx in Kenya
Ann: Agreement with Ilara Health to sell ResAppDx in Kenya, page-76
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)